 LexaGene Holdings, Inc., CVE:LXG OTCQB:LXXGF said it has received approximately C3.6 million US2.9 million in warrant exercises since the start of 2021. In a statement, Dr Jack Regan, LexaGenes CEO and founder commented: Achieving our first commercial sales in combination with a very positive outlook for 2021 has resulted in the appreciation of our share price over the last few months. 